Madison Avenue Partners, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $626 Million distributed in 15 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Graham Holdings CO with a value of $205M, John Wiley & Sons, Inc. with a value of $92M, Theravance Biopharma, Inc. with a value of $89.5M, Acadia Healthcare Company, Inc. with a value of $76.3M, and Endeavor Group Holdings, Inc. with a value of $75M.

Examining the 13F form we can see an decrease of $186M in the current position value, from $812M to 626M.

Madison Avenue Partners, LP is based out at New York, NY

Below you can find more details about Madison Avenue Partners, LP portfolio as well as his latest detailed transactions.

Portfolio value $626 Million
Communication Services: $214 Million
Consumer Defensive: $205 Million
Healthcare: $171 Million
Financial Services: $31 Million
Real Estate: $5 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 15
  • Current Value $626 Million
  • Prior Value $812 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 2 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Madison Avenue Partners, LP Portfolio

Follow Madison Avenue Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Avenue Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Madison Avenue Partners, LP with notifications on news.